Tcheng, J. E., Effron, M., Grines, C. L., Garcia, E., Cox, D., Stuckey, T., … Stone, G. W. (2001). Abciximab use during percutaneous intervention in patients with acute myocardial infarction improves early and late clinical outcomes: Final results of the CADILLAC trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 37(2), 343A-343A.

Tcheng, J. E., M. Effron, C. L. Grines, E. Garcia, D. Cox, T. Stuckey, J. Carroll, et al. “Abciximab use during percutaneous intervention in patients with acute myocardial infarction improves early and late clinical outcomes: Final results of the CADILLAC trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37, no. 2 (February 1, 2001): 343A-343A.

Tcheng JE, Effron M, Grines CL, Garcia E, Cox D, Stuckey T, et al. Abciximab use during percutaneous intervention in patients with acute myocardial infarction improves early and late clinical outcomes: Final results of the CADILLAC trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2001 Feb 1;37(2):343A-343A.

Tcheng, J. E., et al. “Abciximab use during percutaneous intervention in patients with acute myocardial infarction improves early and late clinical outcomes: Final results of the CADILLAC trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 37, no. 2, ELSEVIER SCIENCE INC, Feb. 2001, pp. 343A-343A.

Tcheng JE, Effron M, Grines CL, Garcia E, Cox D, Stuckey T, Carroll J, Guagliumi G, Rutherford B, Lansky AJ, Esente P, Griffin J, Stone GW. Abciximab use during percutaneous intervention in patients with acute myocardial infarction improves early and late clinical outcomes: Final results of the CADILLAC trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2001 Feb 1;37(2):343A-343A.